ClinicalTrials.gg
Enrolling by invitationNCT05803668Updated Jul 18, 2023

Incidence of Cholelithiasis After Bariatric Surgery in Sohag University Hospital

An observational study in Cholelithiasis, sponsored by Sohag University. Enrolling by invitation at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2023-07-18.

Sponsored by Sohag University · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 8 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
30
Sex
All
01

Study summary

To study the incidence and predictors of developing symptomatic gallstone disease following bariatric surgery.

Read the detailed description

To study the incidence and predictors of developing symptomatic gallstone disease following bariatric surgery.

A retrospective study with prospective collective data will be conducted including all patients underwent bariatric surgery in general surgical department, Sohag University between January 2015 and December 2022 who did not have gallstones in the preoperative abdominal ultrasound examinations.

Medical records will be reviewed. Demographic data such as age, gender, BMI, comorbidities as ( DM, hypertension and hyperlipidemia ) and time elapsed between the surgery to post-surgery US examination. The findings of the US examinations will be collected and analyzed. Data will be analyzed to obtain descriptive and inferential statistics.

02

Conditions studied

  • Cholelithiasis

Browse trials for

03

In context

Cholelithiasis

189 studies on the registry are indexed under Cholelithiasis; 42 are open to participants now.

This study's planned enrollment of 30 is below the median of 197 across 50 observational studies indexed under Cholelithiasis.

Browse Cholelithiasis studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients underwent Bariatric Surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All adult patients underwent bariatric surgery with minimum postoperative follow up period of one year duration will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients who had cholecystectomy during the bariatric surgery.
  • Pediatric age.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients who developed gall stones
  • patients who did not develope gall stones
06

What researchers measure

Primary outcomes

  1. Number of patients who develop gall bladder stones after bariatric surgery

    Evalution of gall bladder stone formation postoperaive and its relation with comorbidities

    Time frame: one year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2023 (actual). Primary completion is estimated for Feb 2024, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2023
First posted
Apr 7, 2023
StartActual
Mar 1, 2023
Primary completionEst.
Feb 28, 2024
CompletionEst.
Feb 28, 2024
Last update
Jul 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05803668
Lead sponsor
Sohag University
Responsible party
Ahmed Salah Mohamed (Resident of general surgery of sohag university hospital, Sohag University) — Principal investigator
First posted
Apr 7, 2023
Start date
Mar 1, 2023
Primary completion
Feb 28, 2024 (estimated)
Completion
Feb 28, 2024 (estimated)
Last update
Jul 18, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion